Skip to main content
. 2010 Sep;33(9):2024–2030. doi: 10.2337/dc09-2292

Table 1.

Physical and metabolic characteristics of participants categorized according to fasting glucose levels

FPG
ANOVA P value
≤90 mg/dl >90–<100 mg/dl ≥100–<126 mg/dl
n 40 136 47
Age (years) 12.8 ± 0.4 12.9 ± 0.2 13.2 ± 0.3 0.69
Sex* 0.18*
    Male 11 (27.5) 53 (39) 22 (47)
    Female 29 (72.5) 83 (61) 25 (53)
Race* 0.98*
    African American 16 (40) 60 (44) 22 (47)
    Caucasian 23 (57.5) 73 (54) 24 (51)
    Biracial 1 (2.5) 3 (2.2) 1 (2)
Tanner stage* 0.052*
    I 14 (35) 25 (18.4) 4 (8.5)
    II 3 (7.5) 19 (14) 4 (8.5)
    III 6 (15) 28 (20.6) 10 (21)
    IV 4 (10) 19 (14) 13 (28)
    V 13 (32.5) 45 (33) 16 (34)
Weight (kg) 68.2 ± 5.7 73.0 ± 2.7 82.9 ± 3.9 0.08
Height (cm) 154.2 ± 2.2 156.4 ± 1.1 160.5 ± 1.6 0.07
BMI (kg/m2) 27.1 ± 1.7 28.6 ± 0.8 31.6 ± 1.2 0.07
BMI % 76.2 ± 4.4 82.2 ± 2.1 92.5 ± 2.3 0.005
Fat mass (kg) 24.1 ± 3.2 26.1 ± 1.6 32.2 ± 2.4 0.07
% body fat 33.6 ± 2.5 34.0 ± 1.2 38.0 ± 1.8 0.21
Waist circumference (cm) 85.9 ± 5.0 86.1 ± 2.4 94.7 ± 3.2 0.14
Waist circumference percentile 0.16*
    <75th 12 (40) 34 (37.8) 7 (20)
    75th–90th 6 (20) 12 (13.3) 4 (11.4)
    >90th 12 (40) 44 (48.9) 24 (68.6)
SAT (cm2) 311.7 ± 44.3 337.1 ± 22.3 398.0 ± 32.8 0.25
VAT (cm2) 49.8 ± 6.7 48.5 ± 3.6 56.9 ± 5.1 0.47
Glucose (mg/dl) 87.6 ± 0.3 94.9 ± 0.2 105.0 ± 0.6 <0.001
Insulin (μU/ml) 28.1 ± 4.2 30.5 ± 1.7 40.2 ± 3.6 0.02
A1C (%) 5.3 ± 0.08 5.3 ± 0.04 5.4 ± 0.07 0.56
Cholesterol (mg/dl) 160.8 ± 5.7 164.8 ± 2.4 165.3 ± 5.2 0.75
LDL (mg/dl) 90.1 ± 5.7 98.6 ± 2.1 100.4 ± 5.2 0.2
HDL (mg/dl) 47.0 ± 1.7 45.8 ± 0.9 42.4 ± 1.8 0.11
Triglycerides (mg/dl) 116.9 ± 11.5 102.4 ± 4.6 114.8 ± 10.8 0.29
VLDL (mg/dl) 23.4 ± 2.3 20.3 ± 0.9 21.6 ± 1.8 0.3

Data are unadjusted means ± SEM or n (%). Ten subjects with FPG ≤90 mg/dl, 46 subjects with FPG >90–<100 mg/dl, and 12 subjects with FPG >100–<126 mg/dl did not have waist circumference data because this measurement was implemented late in the course of the grant project.

2 analysis.